Avian pathogenic Escherichia coli (APEC) poses a substantial economic and health challenges for poultry and meat industries. One of the promising alternative approaches to overcome bacterial contamination in food products is bacteriophage, due to its high specificity, safety, and effectiveness. We aimed to isolate a bacteriophage against E. coli causing poultry diseases and investigate its potential as biocontrol/therapeutic agent. A novel E. coli phage vB_EcoP_ZCEC16 was isolated from poultry samples. vB_EcoP_ZCEC16 is a podophage as visualized by transmission electron microscope, and it exhibited a high thermal and pH stability, and high lytic activity at MOIs 0.1 and 1 demonstrated by rapid reduction in bacterial optical density. Whole-genome analysis clustered the phage within Kuravirus genus and confirmed its virulence and the absence of antimicrobial resistance genes. The phage was also safe at high concentration (109 PFU/mL) on human fibroblast cells (HSF) and human colon carcinoma (Caco-2) cell lines as no cytotoxic effect was observed after 24 h. In addition, the lowest tested phage MOI (0.1) was the most protective to HSF cells against bacterial infection. Finally, phage vB_EcoP_ZCEC16 was evaluated for its biocontrol efficacy, where it significantly reduced the count of E. coli contaminating fresh poultry meat after 2 h of treatment. Our study introduced a novel virulent phage with the potential of biocontrol agent for enhancing food safety.
Multidrug-resistant avian pathogenic Escherichia coli (MDR-APEC) causes critically high first-week mortality in chickens, resulting in substantial economic losses in the global poultry industry. This study aimed to isolate and characterize a novel bacteriophage as an effective safe alternative for the control of coliba...
Siwaporn Bilhman, Supakit Paosen, A. Limsatanun et al.· Poultry Science· 0 citations
Colibacillosis caused by avian pathogenic Escherichia coli (APEC) remains an important bacterial disease in poultry production and is increasingly difficult to control because of antimicrobial resistance. In this study, a lytic phage, ND-4, was isolated from poultry-farm sewage using the O2:K1 APEC strain IMT5155 as th...
Le-Ping Wang, Jia-He Zhou, Guo-Tai Liu et al.· Life· 0 citations
Bacteriophages have been widely recognized as one of the most promising alternatives to antibiotics. In this study, a multivalent bacteriophage designated vB_SalM_Sz was isolated, and its whole-genome sequence, biological traits, biosafety profile, and bactericidal activity were comprehensively characterized. Genomic a...
Xin-Yan Yao, Si-Jia Luo, Jing-Hao Xie et al.· Food Research International· 0 citations
Bacteriophage therapy is a promising strategy against multidrug-resistant (MDR) extraintestinal pathogenic
Escherichia coli
(ExPEC), yet bacterial resistance evolution remains a major clinical challenge. In this study, we isolated and comprehensively characterized a novel lytic phage, vB_EcoP_P61425, belonging to t...
Long Chen, Si-Xiang Xu, Xiao-Yue Li et al.· Frontiers in Microbiology· 0 citations
Foodborne diseases impose a considerable global burden, with Shiga toxin-producing
Escherichia coli
(STEC) ranking among the leading bacterial pathogens causing severe human disease. Phages represent a promising alternative for STEC control. Since cattle constitute the main reservoir of STEC, in this study, phages...
A. Juárez, A. Krüger, J. Pomarico et al.· PHAGE· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.